text: Christine Lind new CEO of Medivir AB
  News	Business	Careers	Politics	Companies	Earnings	Economy	Agrifish	Leadership	Crime	Economic Calendar	Travel	Sea, Land, Air	Design	Gadgets	Health	Meantime	Christine Lind new CEO of Medivir AB Staff Writer | Stockholm, Sweden | Friday February 10, 2017 5:09AM ET Medivir AB, a pharmaceutical company, announces that Christine Lind has been appointed as the new CEO of Medivir AB. Ms. Lind will take up her new position on April 1, 2017, until which time she will continue in her existing role as EVP Strategic Business Development.
  Ms. Lind has been Medivir's EVP Strategic Business Development since 2015, prior to which she was VP Business Development at LifeCell Corporation in New Jersey, and has spent the majority of her career at Merrill Lynch & Co. / Bank of America Merrill Lynch in New York, where she specialised in Healthcare Investment Banking.
  Ms. Lind holds a B.Sc. in Finance and Information Systems from New York University and an MBA in Finance and Management from Columbia Business School.
  She succeeds Niklas Prager, who accepted the role as CEO in 2014 from a position as a Director of the Board.
  Mr. Prager will continue as CEO until 1 April and will also make himself available to Ms. Lind until the Annual General Meeting on 3 May, in order to ensure an optimal and smooth transition. ■ LATEST MOVES FROM Sweden Kristina Franzén new CFO at BiliaImmunicum appoints Karin Hoogendoorn as head of CMCKai Wärn proposed as new board member of AB ElectroluxEven Frydenberg new president & CEO for ScandicElectrolux appoints head of major appliances Latin America More inside POSTBritain's cyber security center: We never certified Kaspersky CompaniesBulgaria and Romania to adopt joint strategy on development of Dunabe region Politics Pizza Hut to hire nearly 3,000 delivery drivers every month CompaniesWhat general public expects from senior leaders on social media Leadership	MOST READ MOVES